Niconovum was formed in 2000 by
Dr. Karl Olof Fagerström, one of
the world’s leading experts on
smoking cessation and nicotine
dependence.
Niconovum
believes there is a need for a
range of Nicotine Replacement
Therapy (NRT) products that
deliver nicotine efficiently and
pleasantly – giving
consumers better options to
choose from in order to meet
their personal tobacco reduction
goals.
In 2009, Niconovum was acquired
by Reynolds American Inc. (RAI)
and in 2017, RAI was acquired by
British American Tobacco (BAT).
BAT has a stated ambition to
lead the transformation of the
tobacco industry by offering
adult consumers a range of
potentially reduced-risk
products.